| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |